It has also been reported that intracerebroventricular administration of HMGB1 induces depression‐like behaviors, such as prolonged immobility time in tail suspension test (TST) or forced swimming test (FST) and decreased sucrose preference.7, 8, 9, 10, 11, 12, 13, 14. Here, HMGB1 is linked to depressive disorder.